Table 2 Association of vitamin use and infant leukaemia

From: Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group

 

Controls

Combined cases

ALL

AML

 

N

N

OR a

95% CI

N

OR a

95% CI

N

OR a

95% CI

Prenatal vitamins

 Any prenatal vitamin consumption

No

19

40

1.00

 

28

1.00

 

11

1.00

 

Yes

303

402

0.79

0.44–1.42

235

0.63

0.34–1.18

161

1.20

0.53–2.75

 Periconceptional consumption

No

100

162

1.00

 

104

1.00

 

56

1.00

 

Yes

222

280

0.89

0.64–1.24

159

0.77

0.54–1.11

116

1.05

0.68–1.61

 Consumption during pregnancy, after confirmation of pregnancy

No

29

58

1.00

 

39

1.00

 

18

1.00

 

Yes

293

384

0.78

0.48–1.28

224

0.66

0.39–1.11

154

1.05

0.55–2.04

 Consumption in year before and throughout pregnancy

No

137

222

1.00

 

137

1.00

 

83

1.00

 

Yes

185

220

0.84

0.62–1.14

126

0.77

0.55–1.09

89

0.88

0.60–1.31

Prenatal iron supplements

 Any prenatal iron consumption

No

253

334

1.00

 

195

1.00

 

136

1.00

 

Yes

70

108

1.07

0.75–1.52

68

1.22

0.82–1.80

36

0.82

0.51–1.33

 Periconceptional consumption

No

308

414

1.00

 

247

1.00

 

160

1.00

 

Yes

15

28

1.23

0.63–2.38

16

1.30

0.62–2.72

12

1.26

0.55–2.88

 Consumption during pregnancy, after confirmation of pregnancy

No

260

345

1.00

 

201

1.00

 

141

1.00

 

Yes

63

97

1.06

0.74–1.53

62

1.22

0.81–1.84

31

0.77

0.46–1.27

 Consumption in year before and throughout pregnancy

No

320

431

1.00

 

256

1.00

 

168

1.00

 

Yes

3

11

2.54

0.69–9.39

7

3.04

0.77–12.03

4

1.72

0.33–9.06

  1. Abbreviations: 95% CI=95% confidence interval; ALL=acute lymphoblastic leukaemia; AML=acute myeloid leukaemia; OR=odds ratio.
  2. aORs adjusted for maternal race and household income.